This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...
Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback